BETA: Please send your feedback!
Natera
NTRA:NAS
Biotechnology
$0
SMALL cap
$32.13
(0.83%)
-0.05%
since start of 2020
-17.79
About
Biotechnology
Founded 2003
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test; Horizon Carrier Screening; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis; Anora Products of Conception; and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
website
Headquarters
Executives
| Name | Title | Gender |
| Matthew Rabinowitz, PhD | Chairman, President & Chief Executive Officer | Male |
| Jonathan Sheena | Director & Chief Technology Officer | Male |
| Daniel Rabinowitz | Secretary & General Counsel | Male |
| Mike Brophy, MBA | CFO, Director & Head-Investor Relations | Male |
| Damon Silvestry | Vice President-Operations | Male |
| Michael C. Little, PhD | Senior Vice President-Research & Development | Male |
| Joshua Leichter | Vice President-Legal & Corporate Affairs | Male |
| Cheng-Ho Lin, PhD | Chief Scientific Officer | null |
Mindful Investing Summary
Natera - Competitors and Related Companies
How Natera stacks up to its peers in the Biotechnology industry or with competing business segments.
Natera
NTRA:NAS
Biotechnology
$0
SMALL cap
$32.13
(0.83%)
-0.05%
since start of 2020
-17.79
Paratek Pharmaceuticals
PRTK:NAS
Biotechnology
$194.42mm
SMALL cap
$4.61
(0.39%)
0.14%
since start of 2020
-1.17
Prothena
PRTA:NAS
Biotechnology
$452.19mm
SMALL cap
$11.33
(0.24%)
-0.28%
since start of 2020
-5.82
Pluristem Therapeutics
PSTI:NAS
Biotechnology
$145.93mm
MICRO cap
$8.17
(3.32%)
0.92%
since start of 2020
-3.65
Vertex Pharmaceuticals
VRTX:NAS
Biotechnology
$64.01bn
LARGE cap
$246.89
(-2.77%)
0.12%
since start of 2020
53.92